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ABSTRACT 
 
Stroke is the third most common cause of death and the most common cause of disability in 
adults in developed countries. It is a complex disease in which genetic and environmental 
factors make about equal contributions. A significant proportion of the environmental 
component remains to be elucidated and little is known about which genes that are involved. 
There are two main stroke types; ischemic and hemorrhagic. Both these types have several 
different etiological subtypes.  
 
The specific aim of the present work was to perform clinical association studies to test the 
hypothesis that hemostatic and inflammatory gene polymorphisms, and/or plasma levels of the 
respective proteins, are associated with stroke, and to investigate whether associations differ 
between stroke subtypes.  
 
The studies on ischemic stroke were based on the Sahlgrenska Academy Study on Ischemic 
Stroke (SAHLSIS), in which great emphasize has been put on phenotyping by physical 
examination and neuroimaging. The study comprises 600 consecutive ischemic stroke patients 
presenting with ischemic stroke before the age of 70 years and 600 matched population-based 
controls. Stroke patients were classified according to the main etiological subtypes of ischemic 
stroke, i.e. large-vessel disease (LVD), small-vessel disease (SVD), cardioembolic stroke (CE 
stroke) and cryptogenic stroke. The study on aneurysmal subarachnoid hemorrhage (aSAH) was 
based on patients admitted to the Neurointensive Care Unit, Sahlgrenska. A total of 183 patients 
with a confirmed aneurysmal origin of the SAH were included. Two matched population-based 
controls were recruited for each case. Genotyping was performed using 5´nuclease assays 
(TaqMan) and plasma levels of proteins were determined by immunological methods. 
 
Family history of stroke showed independent association to all ischemic stroke subtypes, except 
CE stroke. In our first genetic association study, the fibrinolytic pathway was studied. A 
reduced risk of ischemic stroke was observed for a genotype combination indicating a high gene 
expression level of both tissue-type plasminogen activator and plasminogen activator inhibitor 
type 1. This association was not detected in aSAH. However, an increased risk of aSAH was 
found for subjects carrying the coagulation factor XIII 34Leu allele. This variant has been 
shown to influence fibrinolysis by affecting the fibrin network. Family history of myocardial 
infarction (MI) only showed association to one ischemic stroke subtype, i.e. LVD. The 
explanation for this may be that atherosclerosis is a common denominator for MI and LVD. In 
support for this hypothesis, increased plasma levels of the inflammatory marker C-reactive 
protein was only found in the LVD group. This is in contrast to the fibrinolytic pathway. Plasma 
levels of tPA, PAI-1 and the fibrinolytic inhibitor TAFI were increased in all ischemic stroke 
subtypes. 
 
In conclusion, the results support a genetic contribution in stroke. This genetic contribution 
seems to differ between subtypes, which highlights the importance of subtype classification in 
stroke research. Furthermore, the findings suggest that inflammatory factors may be of more 
importance for developing LVD, while the fibrinolytic pathway seems to be involved in all 
ischemic stroke subtypes. 
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